ARGORNA PHARMACEUTICALS CO., LTD – Trademark Portfolio
Entity Type: 99
ARGORNA PHARMACEUTICALS CO., LTD holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 5 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 5 trademarks are registered. Notable registered marks include 8, GAIPET, ARGORNA, and ORBICULE.
2nd and 4th Floor, Building A, 7 Suida Street,
Huangpu District, Guangzhou Guangdong
Showing of trademarks Trademarks
Trademark Classifications
ARGORNA PHARMACEUTICALS CO., LTD's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does ARGORNA PHARMACEUTICALS CO., LTD have?
ARGORNA PHARMACEUTICALS CO., LTD has 6 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 abandoned.
What trademark classes does ARGORNA PHARMACEUTICALS CO., LTD file in?
ARGORNA PHARMACEUTICALS CO., LTD files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 42 (Computer & Scientific). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ARGORNA PHARMACEUTICALS CO., LTD's most well-known trademarks?
ARGORNA PHARMACEUTICALS CO., LTD's registered trademark portfolio includes well-known marks such as 8, GAIPET, ARGORNA, and ORBICULE. These are among 5 currently registered trademarks in the portfolio.
What is ARGORNA PHARMACEUTICALS CO., LTD's trademark registration success rate?
ARGORNA PHARMACEUTICALS CO., LTD has a 83% trademark registration rate, with 5 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.